SMTL ID : 6o1v.1

Complex of human cystic fibrosis transmembrane conductance regulator (CFTR) and GLPG1837

Coordinates

PDB Format

Method

ELECTRON MICROSCOPY

Oligo State

hetero-1-1-mer

Ligands

1 x LJP: N-(3-carbamoyl-5,5,7,7-tetramethyl-4,7-dihydro-5H-thieno[2,3-c]pyran-2-yl)-1H-pyrazole-3-carboxamide(Non-covalent)

LJP.1: 10 residues within 4Å: Chain A: L.233, F.236, Y.304, F.305, S.308, A.309, F.312, S.313, G.930, F.931 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:L.233, A:A.309 Hydrogen bonds: A:Y.304, A:Y.304, A:S.308, A:F.931 pi-Stacking: A:F.312

2 x MG: MAGNESIUM ION(Non-covalent)

MG.2: 4 residues within 4Å: Chain A: T.465, Q.493, D.572 Ligands: ATP.4 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:T.465 MG.3: 4 residues within 4Å: Chain A: S.1251, Q.1291, D.1370 Ligands: ATP.5 1 PLIP interactions: 1 interactions with chain A Metal complexes: A:S.1251

2 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)

ATP.4: 18 residues within 4Å: Chain A: W.401, V.440, S.459, T.460, G.461, A.462, G.463, K.464, T.465, S.466, Q.493, Q.1330, C.1344, V.1345, S.1347, H.1348, G.1349 Ligands: MG.2 17 PLIP interactions: 17 interactions with chain A Hydrogen bonds: A:G.461, A:A.462, A:G.463, A:K.464, A:T.465, A:T.465, A:T.465, A:S.466, A:Q.493, A:C.1344, A:S.1347, A:H.1348, A:G.1349 Salt bridges: A:K.464, A:K.464 pi-Stacking: A:W.401, A:W.401 ATP.5: 19 residues within 4Å: Chain A: F.533, I.546, T.547, S.549, G.550, G.551, Q.552, Y.1219, I.1226, T.1246, G.1247, S.1248, G.1249, K.1250, S.1251, T.1252, Q.1291, H.1402 Ligands: MG.3 18 PLIP interactions: 18 interactions with chain A Hydrogen bonds: A:I.546, A:S.549, A:G.551, A:Q.552, A:G.1247, A:G.1247, A:S.1248, A:G.1249, A:K.1250, A:S.1251, A:T.1252, A:T.1252, A:Q.1291 Salt bridges: A:K.1250, A:K.1250, A:H.1402 pi-Stacking: A:Y.1219, A:Y.1219

5 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-functional Binders)(Non-covalent)

POV.6: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) POV.7: 3 residues within 4Å: Chain A: W.216, F.224 Ligands: CLR.11 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.216, A:F.224 POV.8: 2 residues within 4Å: Chain A: L.365, N.369 1 PLIP interactions: 1 interactions with chain A Hydrophobic interactions: A:L.365 POV.9: 2 residues within 4Å: Chain A: V.350, F.354 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:V.350, A:F.354 POV.10: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP)

1 x CLR: CHOLESTEROL(Non-covalent)

CLR.11: 3 residues within 4Å: Chain A: W.216, E.217 Ligands: POV.7 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:W.216, A:E.217

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Liu, F. et al., Structural identification of a hotspot on CFTR for potentiation. Science (2019)

Release Date

2019-06-26

Peptides

Cystic fibrosis transmembrane conductance regulator: A
Unknown Peptide: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Membrane

We predict this structure to be a membrane protein.
Show / Hide

Cystic fibrosis transmembrane conductance regulator

Unknown Peptide

Related Entries With Identical Sequence